The Southern California Chemoprevention Consortium (SCCC), founded in 2003, includes physicians and medical practitioners from across the country. These physicians began their efforts with a focus on conducting cancer chemoprevention clinical trials in the colon, oral cavity, gynecologic (primarily cervix), prostate and skin.
The primary approach has been to identify molecular targets and define a correlation with clinically relevant endpoints, including pathologic changes and imaging characteristics. An additional goal is to explore combinations of agents developed by pharmaceutical industry and provided to the National Cancer Institute (NCI) for collaborative development, as well as commercially available agents and new compounds we may propose.
The SCCC now includes more than 16 sites working together with the Chao Family Comprehensive Cancer Center at UC Irvine to reach the target populations necessary to obtain research data.
View the cancer center's annual report ›
View the center's brochure ›